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Enterovirus 71 (EV71) is a common cause of hand, foot, 
and mouth disease and sometimes causes severe neuro-
logic complications, mainly in children. We report a case 
of adult-onset encephalitis caused by intrafamilial transmis-
sion of a subgenogroup C4 strain of EV71. This case eluci-
dates the risk for EV71 encephalitis even in adults.
I
n children, enterovirus 71 (EV71) is a common cause of 
hand, foot, and mouth disease (HFMD), and most pa-
tients recover within 4–6 days. However, severe neurologic 
complications, such as acute encephalitis and poliolike pa-
ralysis, develop in some patients with EV71 infection. In 
the largest and most severe EV71-associated HFMD out-
break occurring in Taiwan in 1998, 405 children had severe 
neurologic complications, pulmonary edema, or both; 78 
children died (1). In adults, transmission of EV71 within 
households is common, but EV71 infection is commonly 
limited to mild illness, and neurologic complications are 
uncommon in adults (2–4). We report a case of acute EV71 
encephalitis in a mother and cases of HFMD in her 3 sons 
due to intrafamilial transmission of EV71.
The Case
In November 2006, a 37-year-old woman without seri-
ous past illness sought treatment at our hospital with hand 
tremor, unsteadiness, and a 2-day history of headache (day 
1). Examination showed high fever (39.3°C), neck stiff-
ness, intentional tremor of bilateral upper extremities, and 
truncal ataxia. Brain magnetic resonance images (MRI) and 
results of laboratory blood tests were normal. A cerebro-
spinal ﬂ  uid (CSF) tap showed 305 leukocytes/mm3 (82.5% 
polymorphonuclear leukocytes and 17.5% lymphocytes) 
and total protein concentration of 62 mg/dL with normal 
glucose levels. Empirical therapy with acyclovir and cefo-
taxime was initiated. On day 4, the patient reported diplo-
pia and slurred speech. Ocular movements were not obvi-
ously restricted, and the extremities showed ataxia without 
weakness. She could not sit on the bed without support 
because of severe unsteadiness. Deep tendon reﬂ  exes were 
absent, and the patient had no pathologic reﬂ  exes. Brain 
MRI showed hyperintense lesions in the tegmentum of the 
medulla oblongata, pons, and midbrain in T2-weighted 
and ﬂ  uid attenuated inversion recovery images (Figure 1). 
No abnormalities of the cervical spinal cord were detected 
on MRI. Results of nerve conduction studies were within 
normal ranges except for the absence of an F-wave in the 
median and ulnar nerves. Methylprednisolone (1 g/day) 
was administered for 3 days. From day 5 and forward, the 
patient gradually improved. A CSF tap on day 15 showed 
14 leukocytes/mm3 (100% lymphocytes) and a total protein 
concentration of 50 mg/dL. On day 22, MRI showed that 
the brain had normalized. Three months after the onset of 
disease, she had completely recovered. 
During the illness, CSF was negative for bacteria and 
viruses. Enterovirus-speciﬁ   c RNA was detected from a 
stool sample on day 16 by a seminested reverse transcrip-
tion–PCR (RT-PCR) with consensus-degenerative prim-
ers from Nix et al. (5); the virus was identiﬁ  ed as EV71 
by sequence analysis of the partial VP1 region (5). Serum 
neutralizing antibody titer against EV71 increased, from 8 
on day 1 to 128 on day 15. There was no increase in serum 
antibodies against other viruses, including herpes simplex 
virus, cytomegalovirus, varicella-zoster virus, Epstein-Barr 
virus, rubella virus, and mumps virus by enzyme immuno-
assay, and against Japanese encephalitis virus by hemag-
glutination-inhibition test. Results for antinuclear antibody 
and antiganglioside antibodies were also negative.
Three days before the patient sought treatment, her 
1-year-old son was affected with HFMD. This disease also 
developed in her other 2 sons, 5 and 7 years of age, on day 
2. Her 3 children recovered within several days without any 
neurologic complications. Enterovirus-speciﬁ  c RNA was 
also detected in the stool samples from the 3 children by 
seminested RT-PCR (5), and all 3 viruses were identiﬁ  ed as 
EV71 by sequence analysis. In addition, EV71 was isolated 
in Vero cells from stool samples from 2 of the 3 sons with 
HFMD. Stool and other clinical samples from the mother 
were all negative for virus isolation on Vero and RD cells. 
The partial VP1 sequences (150 bp) of the PCR prod-
ucts directly ampliﬁ  ed from stool samples of all 4 cases 
were 100% identical. The entire VP1 sequences (891 bp) 
of the EV71 isolates from 2 of her sons with HFMD (07-
Ishikawa and 08-Ishikawa) were also 100% identical. Phy-
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logenetically, by using VP1-based genetic classiﬁ  cation, 
the isolates were classiﬁ  ed as subgenogroup C4 (Figure 2) 
(6). The subgenogroup C4 of EV71 has recently been iden-
tiﬁ  ed in Japan and might have emerged in the surrounding 
countries, mainland People’s Republic of China and Tai-
wan (6–9). The 07-Ishikawa strain shows a close genetic 
relationship to recent subgenogroup C4 strains in mainland 
China (97.4% nt identity to the SHZH04–38 strain) and 
those in Japan (97.0% nt identity to the 2779-Yamagata 
strain, Figure 2) (7,9).
Conclusions
Several EV71 outbreaks have been documented 
throughout the world, and clinical manifestations of EV71 
infections can be diverse, including HFMD, herpangina, 
central nervous system (CNS) complications, and pulmo-
nary edema. Recently, EV71-associated HFMD outbreaks 
with severe CNS complications have frequently been re-
ported, especially in the Asian-Paciﬁ  c region (2,3). In chil-
dren, the CNS complications associated with EV71 mani-
fest clinically in various ways, such as aseptic meningitis, 
acute ﬂ  accid paralysis, and rhombencephalitis; rhomben-
cephalitis is one of the most common severe neurologic 
symptoms (2). 
We diagnosed the mother’s illness as EV71 encepha-
litis because the clinical features were similar to those of 
EV71 rhombencephalitis in children (2,10), although there 
has not previously been a detailed case report of adult-onset 
EV71 encephalitis. EV71 was not identiﬁ  ed in the mother’s 
CSF sample by virus isolation or direct molecular detection 
by RT-PCR, but EV71 was identiﬁ  ed in her stool sample. 
We could not exclude the possibility of para- or post-in-
fectious encephalitis during the initial stage of her illness. 
However, rhombencephalitis subsequently developed in 
this patient, which is common in children with EV71 en-
cephalitis but is far less common from other infections and 
para- or post-infectious encephalitis. Clinical symptoms, 
MRI, and CSF ﬁ  ndings of her illness were similar to those 
reported in children with EV71 encephalitis.
Several previous studies have demonstrated a rather 
low virus isolation rate in CNS specimens compared with 
that in other clinical samples, such as throat swab, rectal 
swab, and stool samples from EV71-associated cases with 
HFMD, encephalitis, or both (2,3,11). Along with the iden-
tiﬁ  cation of EV71, the increase in serum neutralizing an-
tibody titer against EV71 supports the diagnosis of acute 
EV71 infection. In addition, the lack of abnormalities of 
the spinal cord on MRI, the absence of an F-wave on nerve 
conduction study (a possible sign of radiculopathy), and the 
absence of deep tendon reﬂ  exes without weakness support 
the possibility of radiculitis as a complication. In a previous 
report, some patients with rhombencephalitis showed hy-
poreﬂ  exia or areﬂ  exia, but nerve conduction study ﬁ  ndings 
were not reported (2).
Genetic analysis among 4 different EV71 isolates from 
the patients indicated probable intrafamilial transmission of 
EV71. In a recent study, EV71 transmission rate to house-
hold contacts was 52%, and the transmission rate from 
children to parents was 41% (4). Twenty-one percent of 
EV71-infected children experienced serious complications, 
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Figure 1. Magnetic resonance images of the brain. A) Hyperintense 
lesions in the tegmentum of the pons in the axial section of the 
ﬂ  uid-attenuated inversion recovery image. B) In the sagittal section 
of the T2-weighted image, hyperintense lesions are present in the 
tegmentum of the midbrain, pons, and medulla oblongata.including CNS or cardiopulmonary failure. By contrast, 
53% of adults were asymptomatic, and all symptomatic 
adults recovered completely from uncomplicated illnesses 
(4). Considerable attention has been paid to EV71 infection 
in children because young age was considered the major 
risk factor associated with severe CNS complications, such 
as encephalitis resulting in severe neurologic sequelae and 
deaths (2–4,12). Thus, less attention has been paid to the 
adult-onset EV71 encephalitis. Our patient showed a good 
prognosis; however, a 19-year-old man died from EV71 
encephalitis in Singapore (3). More careful disease surveil-
lance, even for adults, will be needed during EV71-associ-
ated HFMD outbreaks.
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Figure 2. Phylogenetic analysis of EV71 based on the entire VP1 
sequences. The tree was prepared by the neighbor-joining method 
by using the EV71 strains in the world as described previously 
(6) and newly identiﬁ  ed subgenogroup C4 strains (7,8) were also 
included in the analysis.
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